Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
Purpose
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Condition
- Dravet Syndrome
Eligibility
- Eligible Ages
- Over 2 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Criteria
Inclusion Criteria:
- Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all
available medications for seizures.
Study Design
- Phase
- Study Type
- Expanded Access
Recruiting Locations
University of California, Los Angeles
Los Angeles 5368361, California 5332921 90095-1752
Los Angeles 5368361, California 5332921 90095-1752
Contact:
Shaun Hussain, MD
310-206-4037
Shaun Hussain, MD
310-206-4037
More Details
- Status
- Available
- Sponsor
- University of California, Los Angeles
Detailed Description
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.